Skip to main content
. 2022 Mar 26;20:1764–1777. doi: 10.1016/j.csbj.2022.03.024

Fig. 10.

Fig. 10

Predicted anti-H1N1 antibodies titers of in silico patient cohorts exposed to different PFOA concentrations (1st, 2nd, 3rd and 4th quartile) after having received influenza vaccination. These in silico predictions mirror the in vivo observed results depicted in Looker’s work.